-
Ecocide: prosecuting the destruction of ecosystems
19 February 2021There are growing calls for ecocide to be recognised as an offence under the Rome Statute, which would mean individuals - including the heads of companies - could find themselves prosecuted by the International Criminal Court, says Aidan Ellis
-
People Moves 19 February: US Bank; Deloitte; S&P Global; Impact Cubed; First Sentier Investors; AXA IM; Chronos; Triple Point; EBRD; New Forests
19 February 2021 -
BlueOrchard targets infrastructure in bid to draw larger impact investors
19 February 2021BlueOrchard says it is increasingly targeting investments in sustainable infrastructure as it looks to attract large investors including pension funds to make impact investments.
-
S&P hopes ESG-focused US mid- and small-cap indexes will drive reporting
19 February 2021S&P Dow Jones Indices (S&P DJI) hopes that the launch of small- and mid-cap indexes to its environmental, social and governance (ESG)-focused range will help drive greater sustainability reporting and action among these smaller firms
-
The question Morgan Stanley is most asked: Is there a green bubble?
19 February 2021Morgan Stanley has released a report to help investors value environmentally themed-stocks, as it revealed that the most common question it has received over the past month is whether a 'green bubble' has formed
-
US Fed doubts there will be a single "right" approach to climate-related risk
19 February 2021A governor of the US Federal Reserve said it was "unlikely" that there would be a single "right" approach to judging the financial impact of climate change for the central bank, instead encouraging market innovation on the topic.
-
Rise Fund, Generation, CPPIB invest in CSR software provider
19 February 2021TPG's Rise Fund, Generation Investment Management, Canada Pension Plan Investment Board, AIMCo and Vestcor have invested an undisclosed sum in Benevity, a provider of 'corporate purpose' software.
-
Adjuvant raises $300m for healthcare venture fund
18 February 2021Adjuvant Capital has raised $300 million for a venture capital fund that aims to accelerate the development of medicine for 'historically overlooked public health challenges'.
-
Green and sustainability-linked loan round-up: AB InBev, GLP update, Suzano, Thai Union, Enviva ... and more
18 February 2021 -
S&P Global makes over 9,000 ESG Scores publicly available
18 February 2021S&P Global has made its ESG scores on 9,200 companies free to view.